CAS: 1132709-16-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
(1S,2R)-Bortezomib REF: 4Z-B-4676CAS: 1132709-16-0 | - - - | To inquire | Mon 16 Dec 24 | |
(1S,2R)-Bortezomib REF: TR-B675710CAS: 1132709-16-0 | - - - | 124.00 €~1,007.00 € | Tue 17 Dec 24 | |
(1S,2R)-Bortezomib-d5 REF: TR-B675712CAS: 1132709-16-0 | - - - | 9,012.00 € | Fri 17 Jan 25 | |
(1S,2R)-Bortezomib-d5 REF: 3D-HVB70916CAS: 1132709-16-0 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-B-4676
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
(1S,2R)-Bortezomib
Controlled ProductCAS:1132709-16-0
Formula:
C19H25BN4O4
Color and Shape:
Neat
Molecular weight:
384.237
Ref: TR-B675710
5mg | 124.00 € | ||
50mg | 652.00 € | ||
100mg | 1,007.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
(1S,2R)-Bortezomib-d5
Controlled ProductCAS:1132709-16-0
Formula:
C19D5H20BN4O4
Color and Shape:
Neat
Molecular weight:
389.268
Ref: TR-B675712
25mg | 9,012.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
(1S,2R)-Bortezomib-d5
CAS:1132709-16-0
(1S,2R)-Bortezomib-d5 is a modified form of bortezomib that has been radiolabeled with d5. It is …
Formula:
C19H20D5BN4O4
Purity:
Min. 95%
Molecular weight:
389.27 g/mol
Ref: 3D-HVB70916
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |